This study showed that high nuclear expression of HIF-1α and high cytoplasmic expression of HIF-2α indicate unfavorable prognosis in patients with RCC, which may potentially serve as risk stratification markers and even therapeutic targets to manage this disease. The gene discussed is HIF1A; the disease is renal cell carcinoma.